Yaokang Bio: Net profit in the first half of 2025 was 70.9055 million yuan, a year-on-year decrease of 7.12%.

Yaoke Biology announced that its operating income in the first half of 2025 was 375 million yuan, an increase of 10.11% year-on-year. The net profit was 70.9055 million yuan, a decrease of 7.12% year-on-year. The company plans to distribute profits based on the total share capital registered on the record date of equity distribution. For every 10 shares, a cash dividend of 0.3 yuan will be distributed, totaling a planned cash dividend of 12.2697 million yuan. Cash dividends account for 17.30% of the net profit attributable to shareholders of the listed company in the first half of 2025.